Purpose
To fund pre-clinical and manufacturing activities for a novel long-acting injectable formulation of ivermectin.
Grantee
Division
Global Health
Date
NOVEMBER 2025
Region served
AFRICA
Committed amount
$2,981,956
Grant topic
Malaria
Duration (months)
45
Grantee location
Jacou, France
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.